[...] Posted May 17, 2009 Share Posted May 17, 2009 "Olanzapine (Zyprexa, Zyprexa Zydis, Zalasta, Zolafren, Olzapin, Rexapin or in combination with fluoxetine Symbyax) is an atypical antipsychotic, approved by the FDA for the treatment of: schizophrenia on September 6, 1996;[1] depressive episodes associated with bipolar disorder, as part of the Symbyax formulation, on December 24, 2003;[2] acute manic episodes and maintenance treatment in bipolar disorder on January 14, 2004.[3] As part of Symbax for treatment resistant depression March 23, 2009.[4] Off-label uses are listed below." The Olanzapine formulations are manufactured and marketed by the pharmaceutical company Eli Lilly and Company, whose patent for olanzapine proper expires in 2011. Contents More info>>> http://en.wikipedia.org/wiki/Olanzapine John Link to comment Share on other sites More sharing options...
Recommended Posts